(S)-3-(5-Oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile

Catalog No. :
ACKMZX932
CAS No. :
172649-40-0
Molecular Formula :
C17H13F3N2O
Molecular Weight :
318.30

IUPAC Name:(S)-3-(5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile

(S)-3-(5-Oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$152.00Login to see priceIn stockInquiry
2mg95%$227.00Login to see priceIn stockInquiry
5mg95%$386.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-(5-Oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile
IUPAC Name(S)-3-(5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile
MDL No.MFCD00944017
Molecular FormulaC17H13F3N2O
Molecular Weight318.30
SMILESN#CC1=CC=CC([C@@H]2C=C(C(F)(F)F)NC3=C2C(CCC3)=O)=C1
InChI KeyRUVMMEREJMHLOS-LBPRGKRZSA-N
Synonym3-[(4S)-5-OXO-2-(TRIFLUOROMETHYL)-1,4,5,6,7,8-HEXAHYDROQUINOLIN-4-YL]BENZONITRILE;ZD0947;(S)-3-(5-Oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl)benzonitrile;ZD0947 >=98% (HPLC);AZD 0947;AZD0947;AZD-0947;Benzonitrile, 3-[(4S)-1,4,5,6,7,8-hexahydro-5-oxo-2-(trifluoromethyl)-4-quinolinyl]-
CAS No.172649-40-0

Synthetic Route by SureRoute

1. ACKMZX932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKMZX932 route product structure diagram
    ACKMZX932172649-40-0 In Stock
Inquiry

2. ACKMZX932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACKMZX932 route product structure diagram
    ACKMZX932172649-40-0 In Stock
Inquiry

Comments (0)